GeneralConnection.com ➔ Dictionary
Dictionary Search

agio

Synonyms

Noun

1. agiotage

2. premium, exchange premium, charge

Usage
Agios (NASDAQ: AGIO) director converts 1,976 RSUs, holds 8,049 shares - Stock Titan
Agios Pharmaceuticals (AGIO) Is Up 7.4% After Mitapivat RISE UP Data in Sickle Cell Disease - Has The Bull Case Changed? - simplywall.st
Agios Pharmaceuticals, Inc. (AGIO) Discusses New Data and Strategic Expansion in Rare Hematology at EHA Investor Event - Slideshow (NASDAQ:AGIO) 2026-06-15 - Seeking Alpha
AGIO: Mitapivat shows durable efficacy in rare hematology, supporting growth and pipeline expansion - TradingView
Agios Pharmaceuticals (AGIO) Reports Promising Results from Phas - GuruFocus
AGIOS (AGIO) director Catherine Owen Adams converts 1,976 RSUs into common stock - Stock Titan
Technical Reactions to AGIO Trends in Macro Strategies - Stock Traders Daily
How The Tebapivat Setback Is Reframing The Story For Agios Pharmaceuticals (AGIO) - Yahoo Finance
J.P. Morgan Maintains Agios Pharmaceuticals(AGIO.US) With Hold Rating, Maintains Target Price $31 - Moomoo
Agios signs $165M deal for blood disorder drug from Korea’s Oscotec that flunked phase 2 study - Fierce Biotech
Woven Swing Costco Outdoor Patio Swing Agio Woven Patio Swing (#1934256) (down From - TV São Bernardo
AGIO: Mitapivat shows durable efficacy in rare anemias, supporting expansion and strong commercial prospects - TradingView
Why Is Agios Pharmaceuticals (AGIO) Up 8.6% Since Last Earnings Report? - Yahoo Finance
AGIO Maintained by JP Morgan -- Price Target Lowered to $31 - GuruFocus
J.P. Morgan Maintains Agios Pharmaceuticals(AGIO.US) With Hold Rating, Announces Target Price $31 - Moomoo
Sickle cell patients needed fewer transfusions with Agios pill in Phase 3 - Stock Titan
AGIO Secures Global Rights to Late-Stage Rare Blood Disorder Candidate - Yahoo Finance
AGIO Halts Tebapivat Development in Myelodysplastic Syndromes - Yahoo Finance
AGIO's Pyrukynd Gets Approval for Thalassemia in Europe - Yahoo Finance
Rare blood disorder drug deal gives Agios shot at $1B U.S. sales - Stock Titan
Why Agios Pharmaceuticals (AGIO) Is Down 5.4% After Overhauling Its Hematology Portfolio - And What's Next - simplywall.st
Agios to stop tebapivat in LR-MDS, plans sickle cell data in 2H 2026 - Stock Titan
A Look At Agios Pharmaceuticals (AGIO) Valuation After The Cevidoplenib Licensing Agreement - simplywall.st
Agios’ next-gen PK drug fails blood cancer study but sickle cell disease ambitions remain undimmed - Fierce Biotech
Agios slides after discontinuing development of tebapivat in myelodysplastic syndromes (AGIO) - Yahoo Finance
Agios Pharmaceuticals licenses global rights to Oscotec's SYK inhibitor cevidoplenib - Proactive financial news
Agios to drop myelodysplastic syndromes drug (AGIO:NASDAQ) - Seeking Alpha
AGIO: Strategic ITP expansion with cevidoplenib offers strong clinical promise and disciplined financials - TradingView
AGIO: Cevidoplenib licensed for ITP, with strong phase II data and phase III planned for 2028 - TradingView
Agios Halts Tebapivat Trials As Sickle Cell Focus Shapes Valuation - simplywall.st
AGIO: Exclusive global license for cevidoplenib expands rare hematology pipeline and targets ITP - TradingView
Trading the Move, Not the Narrative: (AGIO) Edition - Stock Traders Daily
(AGIO) Volatility Zones as Tactical Triggers - Stock Traders Daily
AGIO: Cevidoplenib licensed for ITP, with strong phase II data and phase III planned for 2028 - TradingView
HC Wainwright Issues Optimistic Estimate for AGIO Earnings - MarketBeat
Assessing Agios Pharmaceuticals (AGIO) Valuation After Recent Share Price Volatility - Yahoo Finance
Costco patio swings recalled after reports of injuries from falls - ABC News - Breaking News, Latest News and Videos
Agios Pharmaceuticals Secures Exclusive Global Rights to Next-Generation SYK Inhibitor Cevidoplenib for Immune Thrombocytopenia Treatment - Quiver Quantitative
AGIO Secures Global Rights to Late-Stage Rare Blood Disorder Candidate - The Globe and Mail
Agios Pharmaceuticals, Inc. Stock 12‑Month Price Target Cut to $40.88, Implies 34% Upside - TradingView
Analysts Offer Insights on Healthcare Companies: Becton Dickinson (BDX), Agios Pharma (AGIO) and Healthequity (HQY) - The Globe and Mail
EU clears sole approved drug for adults with alpha- or beta-thalassemia - Stock Titan
A Look At Agios Pharmaceuticals (AGIO) Valuation After Recent Share Price Momentum - Yahoo Finance
Agios Pharmaceuticals (AGIO) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
BofA Reaffirms Buy Rating for Agios Pharmaceuticals (AGIO) - Yahoo Finance
After $665 mil. Agios deal, Oscotec maps 2028 phase 3 path for blood disorder drug - koreabiomed.com
Analysts Are Bullish on Top Healthcare Stocks: Agios Pharma (AGIO), Cogent Biosciences (COGT) - The Globe and Mail
Agios Halts Tebapivat Trials As Sickle Cell Focus Shapes Valuation - Sahm
Costco shoppers need to check their backyards immediately for this recalled patio swing - AL.com
Do Upbeat EPS Revisions Before Earnings Quietly Reframe Agios Pharmaceuticals’ (AGIO) Risk‑Reward Profile? - Yahoo Finance
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia - Business Wire
$AGIO stock is down 22% today. Here's what we see in our data. - Quiver Quantitative
H.C. Wainwright Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Maintains Target Price $50 - 富途牛牛
Agios Pharmaceuticals (AGIO) Moves 14.3% Higher: Will This Strength Last? - Yahoo Finance
Here's Why Agios Pharmaceuticals Crashed 23% Today - Yahoo Finance
Goldman Sachs Maintains Agios Pharmaceuticals(AGIO.US) With Hold Rating, Raises Target Price to $32 - 富途牛牛
Why Did AGIO Stock Surge 14% Today? - Stocktwits
Agios Pharmaceuticals (AGIO) Secures EU Approval for PYRUKYND - GuruFocus
Agios halts tebapivat in lower-risk MDS after Phase 2b failure - grafa.com
Earnings Preview: Agios Pharmaceuticals (AGIO) Q1 Earnings Expected to Decline - Yahoo Finance
Insider Sells AGIO Shares Worth $82,000 -- But Context Is Everything - The Motley Fool
18,500 patio swings sold at Costco recalled after seats detach, causing injuries - Houston Chronicle
Agios scraps blood disorder drug program after study miss - TradingView
Agios Pharmaceuticals (AGIO) Is Up 5.4% After Mixed 2025 Results And AQVESME Launch Progress - Yahoo Finance
Agios Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Agios (NASDAQ: AGIO) doubles mitapivat revenue and funds 2026 pipeline catalysts - Stock Titan
Here's Why Agios Pharmaceuticals Crashed 23% Today - The Motley Fool
AGIO's Pyrukynd Gets Approval for Thalassemia in Europe - The Globe and Mail
ATTENTION AGIO SHAREHOLDERS: Investors who lost money on Agios Pharmaceuticals, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation - PR Newswire
Here's Why Agios Pharmaceuticals Stock Slumped This Week (And What Investors Have to Look Forward to in 2026) - Yahoo Finance
AGIOS PHARMACEUTICALS ($AGIO) Releases Q1 2026 Earnings - Quiver Quantitative
$AGIO stock is up 17% today. Here's what we see in our data. - Quiver Quantitative
Agios Pharmaceuticals stock tumbles 25% after Novo data - Investing.com
Vanguard Capital Management (NASDAQ: AGIO) reports 3.09M shares, 5.27% ownership - Stock Titan
AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD - Zacks Investment Research
AGIO Stock Slumps 25% – What’s The Novo Connection? - Stocktwits
Over 18K porch swings sold at Costco recalled. See affected products - USA Today
New thalassemia drug writes 242 U.S. scripts as Agios plans sickle cell filing - Stock Titan
Lynx1 (AGIO) discloses 5.1% stake — 3.01M shares reported - Stock Titan
How The Agios Pharmaceuticals (AGIO) Story Is Shifting After Aqvesme Approval And New Targets - Yahoo Finance
Armistice Capital (NASDAQ: AGIO) holds 2.716M shares, 4.57% stake - Stock Titan
Agios (NASDAQ: AGIO) executive granted 14,000 RSUs and 52,000 options - Stock Titan
New pill for sickle cell moves to FDA review, aims to cut transfusions - Stock Titan
Agios (AGIO) Q1 2026 Earnings Call Transcript - The Motley Fool
Agios Pharmaceuticals (AGIO) Sees Significant Decline in Stock P - GuruFocus
Agios (NASDAQ: AGIO) CLO exercises 8,500 PSUs and sells shares for taxes - Stock Titan
Oral drug lifts hemoglobin in sickle cell and thalassemia trial - Stock Titan
AGIO (NASDAQ: AGIO) pre-sale notice — 3,141 RSU shares vesting - Stock Titan
Price-Driven Insight from (AGIO) for Rule-Based Strategy - Stock Traders Daily
Agios Pharmaceuticals, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Agios Pharmaceuticals Stock Declines 23% in 6 Months: Here's Why - Yahoo Finance
AGIO (NASDAQ: AGIO) affiliate files to sell 2,940 shares after RSU vesting - Stock Titan
Why Agios Pharmaceuticals Stock Is Up More Than 21% Today - The Motley Fool
Agios Pharmaceuticals Reports Fourth Quarter 2025 Financial Results and Availability of AQVESME™ for Thalassemia - Quiver Quantitative
AGIO Beats on Q1 Earnings & Sales, Stock Up 13% on New Drug Momentum - TradingView
Agios Seeks FDA Nod to Expand Mitapivat Label in Sickle Cell Disease - Yahoo Finance
Agios to seek accelerated approval in US of oral mitapivat for SCD - Sickle Cell Disease News
Agios slides after discontinuing development of tebapivat in myelodysplastic syndromes (AGIO) - MSN
Here's Why Shares in Agios Pharmaceuticals Soared This Week (And What to Expect Next in 2026) - The Motley Fool
Why Novo Nordisk's Surprise Win Hammered Agios Pharmaceuticals Stock - Investor's Business Daily
Foreign Language Equivalents
Foreign Language Equivalents of 'agio'
Language Equivalent   Language Equivalent
French agio    Spanish
Misspellings - Typos
aguo,   aagio,   sgio,   ahio,   agoo,   aigo,   gaio,   gio,   agi,   ago,   agip,   agii,   aggio,   afio,   agoi,   agioo,   agiio,   aio
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z